Hcv Cirrhosis published presentations and documents on DocSlides.
qd. Non-randomised. Open-label. N =. 21. W12. SV...
Open-label. Chronic HCV infection. Genotype 1 . F...
W24. DCV + PR. Placebo + PR. Yes. Dore GJ. Gastro...
David Spach, MD. Clinical Director, Northwest AET...
Randomisation*. Open-label. >. 18 years. HCV ...
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
Nina Kim, MD . Associate Professor of Medicine. D...
Hepatitis-2015. Orlando, USA. July 20 - 22 2015...
Open label. ≥ . 18 years, . HCV genotype 1 to ...
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
C. IN PEOPLE WHO USE DRUGS. Improving . Care for ...
Associate Professor, Johns Hopkins Bloomberg Scho...
RBV . versus. Interferon alfa. -. 2a + RBV . ACT...
LANDLORD BRIEFING. 2015. KHRA & HCV ~ Overvie...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
. The temporal dimension of . diagnosis. Gennaro...
Updated: . July . 6. , . 2015. Treatment of Hepat...
in genotypes 1 or 3, with or without cirrhosis. &...
BID versus q8 in Treatment Naïve GT-1. OPTIMIZE ...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
in DAA. -Naïve GT . 1-6 . POLARIS-2. Phase 3. ...
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
Diagnostic and clinical manifestations. Hepatic d...
A Crisis in the Making. An Assessment of Liver Di...
University of Alberta. Incidence of HCV Infection...
Randomisation. 1 : 1. 18-70 years. HCV genotype 1...
DSV . placebo. Randomisation*. Partial blind. 1...
≥ 18 years. Chronic HCV infection. Genotype 1. ...
Ribavirin in PI-experienced HCV GT1. C-SALVAGE...
Sclerosing. Cholangitis. Srinivasan Dasarathy MD...
12. (HCV RNA < 25 IU/ml), . with. 95% CI. DC...
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
18-70 years. HCV genotype 1 or 3. Naïve or failu...
Wirach Maek-a-nantawat, MD.. 11 July 2011. Conte...
Division of Infectious Diseases. University of Wa...
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
Prevalence. . among. . People. . Who. . Injec...
Copyright © 2024 DocSlides. All Rights Reserved